TR200002118T2 - Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması. - Google Patents

Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması.

Info

Publication number
TR200002118T2
TR200002118T2 TR2000/02118T TR200002118T TR200002118T2 TR 200002118 T2 TR200002118 T2 TR 200002118T2 TR 2000/02118 T TR2000/02118 T TR 2000/02118T TR 200002118 T TR200002118 T TR 200002118T TR 200002118 T2 TR200002118 T2 TR 200002118T2
Authority
TR
Turkey
Prior art keywords
ulcers
calf
treatment
decubitic
powder preparations
Prior art date
Application number
TR2000/02118T
Other languages
English (en)
Turkish (tr)
Inventor
Bohn Manfred
Theodor Kraemer Karl
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200002118T2 publication Critical patent/TR200002118T2/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
TR2000/02118T 1998-01-24 1999-01-11 Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması. TR200002118T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren

Publications (1)

Publication Number Publication Date
TR200002118T2 true TR200002118T2 (tr) 2000-12-21

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02118T TR200002118T2 (tr) 1998-01-24 1999-01-11 Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması.

Country Status (27)

Country Link
US (1) US6534528B1 (enExample)
EP (1) EP1049468B1 (enExample)
JP (1) JP5127091B2 (enExample)
KR (1) KR100597332B1 (enExample)
CN (1) CN1128619C (enExample)
AR (1) AR016445A1 (enExample)
AT (1) ATE360418T1 (enExample)
AU (1) AU752406B2 (enExample)
BR (1) BR9907734A (enExample)
CA (1) CA2319359C (enExample)
CY (1) CY1106684T1 (enExample)
DE (2) DE19802708A1 (enExample)
DK (1) DK1049468T3 (enExample)
ES (1) ES2285829T3 (enExample)
HR (1) HRP20000496A2 (enExample)
HU (1) HU228824B1 (enExample)
IL (1) IL137453A (enExample)
ME (1) MEP55908A (enExample)
NZ (1) NZ505898A (enExample)
PL (1) PL192550B1 (enExample)
PT (1) PT1049468E (enExample)
RS (1) RS50903B (enExample)
RU (1) RU2212239C2 (enExample)
SI (1) SI1049468T1 (enExample)
SK (1) SK285350B6 (enExample)
TR (1) TR200002118T2 (enExample)
WO (1) WO1999037300A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
ES2525387T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Composiciones que contienen peróxido de hidrógeno o sustancias que ponen en libertad peróxido de hidrógeno
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
RS61907B1 (sr) 2015-04-06 2021-06-30 Subdomain Llc Polipeptidi koji sadrže de novo vezujući domen i njihova primena

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
AR242187A1 (es) * 1986-04-18 1993-03-31 Hoechst Ag Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
PT865278E (pt) * 1995-12-04 2002-10-31 Aventis Pharma Gmbh Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele

Also Published As

Publication number Publication date
DK1049468T3 (da) 2007-07-30
HUP0200851A1 (hu) 2002-07-29
HRP20000496A2 (en) 2000-12-31
DE19802708A1 (de) 1999-07-29
YU43700A (sh) 2003-08-29
PL192550B1 (pl) 2006-11-30
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
AU752406B2 (en) 2002-09-19
CA2319359A1 (en) 1999-07-29
AR016445A1 (es) 2001-07-04
SK285350B6 (sk) 2006-11-03
JP2002501020A (ja) 2002-01-15
US6534528B1 (en) 2003-03-18
EP1049468B1 (de) 2007-04-25
AU2278799A (en) 1999-08-09
ATE360418T1 (de) 2007-05-15
IL137453A (en) 2005-11-20
EP1049468A1 (de) 2000-11-08
HU228824B1 (en) 2013-05-28
NZ505898A (en) 2002-06-28
PL342055A1 (en) 2001-05-21
BR9907734A (pt) 2000-10-17
MEP55908A (en) 2011-05-10
SI1049468T1 (sl) 2007-08-31
PT1049468E (pt) 2007-05-31
CA2319359C (en) 2008-03-18
CY1106684T1 (el) 2012-05-23
KR20010034325A (ko) 2001-04-25
IL137453A0 (en) 2001-07-24
ES2285829T3 (es) 2007-11-16
DE59914312D1 (de) 2007-06-06
SK10892000A3 (sk) 2000-12-11
HUP0200851A3 (en) 2003-05-28
CN1128619C (zh) 2003-11-26
CN1288380A (zh) 2001-03-21
RS50903B (sr) 2010-08-31
KR100597332B1 (ko) 2006-07-10
JP5127091B2 (ja) 2013-01-23
RU2212239C2 (ru) 2003-09-20
HK1034447A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
TR199800815A2 (en) S�lfonilaminokarbonasitler.
TR199902904T2 (xx) Yeni bile�imler.
ATE233735T1 (de) Neue phenanthridine
TR200000482T2 (tr) N-Aroilfenilalanin türevleri.
TR200001706T2 (tr) Fosfodiester IV inhibisyonuna sahip purin türevleri
ID28793A (id) Benda penyerap yang sangat efisien untuk digunakan dengan celana menstruasi
TR200000197T2 (tr) Yeni bileşimler
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
NO20010228D0 (no) Farmasöytiske preparater omfattende 2-kinoloner
BG104056A (en) Triazole compounds and their use as dopamine-d3-ligands
MX9709915A (es) Heterociclos de peptidilo y composiciones que los contienen, utiles en el tratamiento de trastornos relacionados con trombina, y uso de los mismos.
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
FI973151L (fi) Kanninpartikkelit käytettäväksi kuivajauheinhalaattoreissa
NO953070L (no) 4-hydroksy-benzopyran-2-oner og 4-hydroksysykloalkyl[BÅpyran-2-oner anvendbare for behandling av retrovirusinfeksjoner
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
ES2161279T3 (es) Nucleosidos y nucleotidos que contienen racimos de boro.
TR199900656T2 (xx) �ndanonlar ile 262 ve 20S proteazomun engellenmesi.
FI980546A0 (fi) Koppling foer att reglera impedansen i en differential aktivkomponent
IT1285770B1 (it) Composti corticoidei
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
RU95101375A (ru) Производные n-(3-аминопропил)-n-фенил-5,6,7,8-тетрагидронафталин-2-карбоксамида, их получение и применение в терапии
FI893579A7 (fi) Stabiloituja vetyperoksidikoostumuksia
TR200002118T2 (tr) Baldırdaki ülserlerin ve dekubitik ülserlerin tedavisinde pudra müstahzarlarının kullanılması.
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung